Echo Therapeutics to Present at the Oppenheimer Healthcare Conference

^{Published on 2011-12-07 04:46:22 - Market Wire}
 

Echo Therapeutics to Present at the Oppenheimer Healthcare Conference -- PHILADELPHIA, Dec. 7, 2011 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about ECTE

PHILADELPHIA, Dec. 7, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: [ ECTE ]), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., Chairman & CEO of Echo Therapeutics, will present at the Oppenheimer 22nd Annual Healthcare Conference.

Dr. Mooney will make a presentation to prospective corporate partners and investors on Wednesday, December 14th at 3:20 PM ET.  The Company's presentation will be delivered at the Waldorf Astoria Hotel in New York City.  

About Echo Therapeutics

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

For More Information:
Christine Olimpio
Director, Investor Relations & Corporate Communications
(215) 717-4104

SOURCE Echo Therapeutics, Inc.